Healthcare & Life Sciences

Constellation Pharmaceuticals

series-b
series-b
Stage
1
Investors

About

Constellation Pharmaceuticals is a biopharmaceutical company focused on developing novel epigenetic therapies targeting cancer and other serious diseases.

Explore Constellation Pharmaceuticals's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.